Guardant Health Announces Colorectal Cancer Blood Test for Average-Risk Adults
Today, precision oncology company Guardant Health announced the availability of Shield, a blood-based test for the detection of early-stage colorectal cancer (CRC)….
Our Shield™ blood test gains FDA approval, ushering in a new era of colorectal cancer screening. More details
Today, precision oncology company Guardant Health announced the availability of Shield, a blood-based test for the detection of early-stage colorectal cancer (CRC)….
